Respiratory Disease Management
| Status: | Completed |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 64 |
| Updated: | 4/2/2016 |
| Start Date: | July 2012 |
| End Date: | October 2015 |
| Contact: | Marin Kollef, MD |
| Email: | MKOLLEF@dom.wustl.edu |
| Phone: | 314 454-8764 |
Use of a Respiratory Care Practitioner Disease Management (RCP-DM) Program for Patients Hospitalized With COPD
The aim of this study is to reduce the number of subsequent hospital admissions and/or
emergency department (ED) visits for hospitalized patients with chronic obstructive
pulmonary disease (COPD) by utilizing a respiratory care practitioner-led disease management
(RCP-DM) program compared to standard discharge instructions and planning.
emergency department (ED) visits for hospitalized patients with chronic obstructive
pulmonary disease (COPD) by utilizing a respiratory care practitioner-led disease management
(RCP-DM) program compared to standard discharge instructions and planning.
The investigators propose to carry out a prospective, randomized, trial at Barnes-Jewish
Hospital (1250-bed urban academic hospital). Eligible patients will be identified by a
senior study coordinator who will also obtain informed consent for study participation.
Adults greater than 18 years of age and less than 65 years of age will be eligible for
enrollment if the lead investigator and the treating physician agree that the patient meets
the enrollment criteria which include the following: patients with spirometrically confirmed
COPD at high risk for repeat hospitalization or ED visits as predicted by hospital admission
or ED visit in the previous 12 months for a COPD exacerbation, chronic home use of oxygen,
or a course of systemic corticosteroid therapy in the preceding 12 months. Exclusion
criteria include patients not expected to survive their hospitalization, presence of
metastatic cancer, bed-bound individuals, non-English speaking patients, and patients unable
to provide informed consent.
Hospital (1250-bed urban academic hospital). Eligible patients will be identified by a
senior study coordinator who will also obtain informed consent for study participation.
Adults greater than 18 years of age and less than 65 years of age will be eligible for
enrollment if the lead investigator and the treating physician agree that the patient meets
the enrollment criteria which include the following: patients with spirometrically confirmed
COPD at high risk for repeat hospitalization or ED visits as predicted by hospital admission
or ED visit in the previous 12 months for a COPD exacerbation, chronic home use of oxygen,
or a course of systemic corticosteroid therapy in the preceding 12 months. Exclusion
criteria include patients not expected to survive their hospitalization, presence of
metastatic cancer, bed-bound individuals, non-English speaking patients, and patients unable
to provide informed consent.
Inclusion Criteria:
- Adults greater than 18 years of age and less than 64 years of age will be eligible
for enrollment if the lead investigator and the treating physician agree that the
patient meets the enrollment criteria which include the following:
- patients with spirometrically confirmed COPD at high risk for repeat
hospitalization or emergency department (ED) visits as predicted by hospital
admission or ED visit in the previous 12 months for a COPD exacerbation,
- chronic home use of oxygen, or
- a course of systemic corticosteroid therapy in the preceding 12 months.
Exclusion Criteria:
- patients not expected to survive their hospitalization,
- presence of metastatic cancer,
- bed-bound individuals,
- non-English speaking patients, and
- patients unable to provide informed consent.
We found this trial at
1
site
Barnes Jewish Hospital Barnes-Jewish Hospital at Washington University Medical Center is the largest hospital in...
Click here to add this to my saved trials
